Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Prelude Therapeutics Granted U.S. Patent # US 12448389 B2 For BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

Author: Benzinga Newsdesk | October 21, 2025 03:00pm

https://ppubs.uspto.gov/api/pdf/downloadPdf/12448389?requestToken=eyJzdWIiOiJlZWQ3ZTE2MS1kZjI1LTQyNTktODVjNy02NmE4NGMzYWM1ZDciLCJ2ZXIiOiI4MTIyZTkxZi03ZTI2LTQwYjMtYjQ0Ni04MTkyZjcyZWUzYzkiLCJleHAiOjB9

Posted In: PRLD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist